Maxim Group Initiates Coverage On Cryo-Cell International with Buy Rating, Announces Price Target of $12
Benzinga Newsdesk 4 years ago
NewsPrice TargetInitiationAnalyst Ratings
Maxim Group analyst Allen Klee initiates coverage on Cryo-Cell International (NASDAQ:CCEL) with a Buy rating and announces Price Target of $12.
Maxim Group analyst Allen Klee initiates coverage on Cryo-Cell International (NASDAQ:CCEL) with a Buy rating and announces Price Target of $12.
